Abiopharma

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Cingulate Inc. Reports First Quarter 2025 Financial Results and Provides an Updated Timeline of Key Developments for its lead ADHD and Anxiety Assets

Ecolab Annual Meeting Results Announced

Ecolab Inc. - Ecolab Declares Cash Dividend

HealthStream Announces Share Repurchase Program

Ecolab Declares Cash Dividend

BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025

Galecto Reports First Quarter 2025 Operating and Financial Results

Sarepta Therapeutics to Present at the BofA Securities Health Care Conference

Cingulate Inc. Reports First Quarter 2025 Financial Results and Provides an Updated Timeline of Key Developments for its lead ADHD and Anxiety Assets